Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

P. Jain; J. Gutierrez Bugarin; A. Guha; C. Jain; N. Patil; T. Shen; I. Stanevich; V. Nikore; K. Margolin; M. Ernstoff; V. Velcheti; J. Barnholtz-Sloan; A. Dowlati

doi:10.1016/j.esmoop.2021.100286

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

P. Jain, J. Gutierrez Bugarin, A. Guha, C. Jain, N. Patil, T. Shen, I. Stanevich, V. Nikore, K. Margolin, M. Ernstoff, V. Velcheti, J. Barnholtz-Sloan, A. Dowlati

Cardiology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	Undefined
Journal	ESMO Open
DOIs	https://doi.org/10.1016/j.esmoop.2021.100286
State	Published - Dec 2021

Access to Document

10.1016/j.esmoop.2021.100286

Cite this

Jain, P., Bugarin, J. G., Guha, A., Jain, C., Patil, N., Shen, T., Stanevich, I., Nikore, V., Margolin, K., Ernstoff, M., Velcheti, V., Barnholtz-Sloan, J., & Dowlati, A. (2021). Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’. ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100286

Jain, P, Bugarin, JG, Guha, A, Jain, C, Patil, N, Shen, T, Stanevich, I, Nikore, V, Margolin, K, Ernstoff, M, Velcheti, V, Barnholtz-Sloan, J & Dowlati, A 2021, 'Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’', ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100286

@article{c693d9347b954984ad184a2f76e26242,

title = "Corrigendum to {\textquoteleft}Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States{\textquoteright}",

author = "P. Jain and Bugarin, {J. Gutierrez} and A. Guha and C. Jain and N. Patil and T. Shen and I. Stanevich and V. Nikore and K. Margolin and M. Ernstoff and V. Velcheti and J. Barnholtz-Sloan and A. Dowlati",

year = "2021",

month = dec,

doi = "10.1016/j.esmoop.2021.100286",

language = "Undefined",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

AU - Jain, P.

AU - Bugarin, J. Gutierrez

AU - Guha, A.

AU - Jain, C.

AU - Patil, N.

AU - Shen, T.

AU - Stanevich, I.

AU - Nikore, V.

AU - Margolin, K.

AU - Ernstoff, M.

AU - Velcheti, V.

AU - Barnholtz-Sloan, J.

AU - Dowlati, A.

PY - 2021/12

Y1 - 2021/12

UR - https://doi.org/10.1016/j.esmoop.2021.100286

U2 - 10.1016/j.esmoop.2021.100286

DO - 10.1016/j.esmoop.2021.100286

M3 - Article

C2 - 34678570

SN - 2059-7029

JO - ESMO Open

JF - ESMO Open

ER -

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

Access to Document

Other files and links

Cite this